Mjb. Wissink et al., Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices, J CONTR REL, 64(1-3), 2000, pp. 103-114
Endothelial cell seeding, a promising method to improve the performance of
small-diameter vascular grafts, requires a suitable substrate, e.g. crossli
nked collagen. In addition, the growth of seeded endothelial cells can be i
mproved by local release of a heparin-binding protein, basic fibroblast gro
wth factor (bFGF). In this study, the influence of immobilization of hepari
n to collagen, crosslinked using N-(3-dimethylaminopropyl)-N'-ethylcarbodii
mide (EDC) in combination with N-hydroxysuccinimide (NHS), on the binding a
nd release of bFGF was determined. Heparin was immobilized also using EDC a
nd NHS. Furthermore, the effects of the release of bFGF from (heparinized)
EDC/NHS-crosslinked collagen on the proliferation of seeded endothelial cel
ls was studied in vitro. Immobilization of increasing amounts of heparin to
EDC/NHS-crosslinked collagen (containing 14 free epsilon-amino groups per
1000 amino acid residues, E/N14C) resulted in binding of increasing amounts
of bFGF to the material. Maximal bFGF binding was observed for E/N14C cont
aining 20-30 mg heparin immobilized per gram of collagen which was obtained
using a molar ratio of EDC to heparin-carboxylic acid groups of 0.4 for he
parin immobilization (E/N14C-H(0.4)). Up to concentrations of 320 ng bFGF/m
l, 10% of the added bFGF bound to E/N14C, while binding of bFGF to E/N14C-H
(0.4) was 22%. The initial release rate of bFGF bound to E/N14C was much hi
gher compared to bFGF bound to E/N14C-H(0.4): respectively, 30 vs. 2% in th
e first 6 h. After 10 days, the bFGF release from E/N14C and E/N14C-H(0.4)
amounted to 83 vs. 42%, respectively. Binding of increasing amounts of bFGF
resulted in increased growth of human umbilical vein endothelial cells (HU
VECs) seeded on both E/N14C and E/N14C-H(0.4). Nevertheless, after 6 and 10
days of proliferation cell numbers on E/N14C-H(0.4) where higher than cell
numbers on E/N14C, irrespective of the bFGF concentration used for loading
of the matrix. It is concluded that heparinized, EDC/NHS-crosslinked colla
gen is a good synthetic vascular graft coating for in vivo endothelial cell
seeding. (C) 2000 Elsevier Science B.V. All rights reserved.